HEPARIN-INDUCED THROMBOCYTOPENIA SUCCESSFULLY TREATED WITH FONDAPARINUX

被引：3

作者：

Seldrum, S. ^{[1
]}

Lambert, M. ^{[1
]}

Hainaut, Ph. ^{[1
]}

机构：

[1] Clin Univ St Luc, Serv Med Interne Gen, B-1200 Brussels, Belgium

来源：

ACTA CLINICA BELGICA | 2009年 / 64卷 / 02期

关键词：

heparin-induced thrombocytopenia; anticoagulants; fondaparinux; thrombo-embolism; PENTASACCHARIDE;

D O I：

10.1179/acb.2009.024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report the successful treatment of a patient with HIT-associated venous thrombosis by fondaparinux, a synthetic pentasaccharide. Although not yet approved for this indication, this new anticoagulant may be a useful alternative in the setting of HIT.

引用

页码：144 / 146

页数：3

共 50 条

[21] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
Fahad A. S. Al-Eidan
Saud Alrawkan
Huda Alshammary
Mark A. Crowther
Annals of Hematology, 2018, 97 : 2055 - 2059
[22] Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia A case report
He, Yumiao
He, Huaiwu
Liu, Dawei
Long, Yun
Su, Longxiang
Cheng, Wei
MEDICINE, 2018, 97 (37)
[23] Heparin-induced thrombocytopenia in surgical patients
Battistelli, Sandra
Genovese, Alberto
Gori, Tommaso
AMERICAN JOURNAL OF SURGERY, 2010, 199 (01) : 43 - 51
[24] A Case of Heparin Induced Thrombocytopenia Treated with Fondaparinux
Alpay, Nilufer
Okumus, Gulfer
Kiyan, Esen
Diz-Kucukkaya, Reyhan
Tabak, Levent
Ece, Turhan
Arseven, Orhan
TURKISH THORACIC JOURNAL, 2009, 10 (04) : 193 - 195
[25] Special considerations with fondaparinux therapy: Heparin-induced thrombocytopenia and wound healing
Dager, WE
Andersen, J
Nutescu, E
PHARMACOTHERAPY, 2004, 24 (07): : 88S - 94S
[26] Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia
Schindewolf, Marc
Steindl, Julia
Beyer-Westendorf, Jan
Schellong, Sebastian
Dohmen, Pascal Maria
Brachmann, Johannes
Madlener, Katharina
Poetzsch, Bernd
Klamroth, Robert
Hankowitz, Johannes
Banik, Norbert
Eberle, Sonja
Mueller, Markus Michael
Kropff, Stefan
Lindhoff-Last, Edelgard
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2636 - 2648
[27] Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia
Snodgrass, Megan N.
Shields, Jenna
Rai, Hema
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (08) : 712 - 717
[28] Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials
Linkins, Lori-Ann
Hu, George
Warkentin, Theodore E.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (04) : 678 - 683
[29] Fondaparinux for the Treatment of Acute Heparin-Induced Thrombocytopenia: A Single-Center Experience
Grouzi, Elisavet
Kyriakou, Elias
Panagou, Ioannis
Spiliotopoulou, Ioanna
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (06) : 663 - 667
[30] Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill
Wester, J. P. J.
Leyte, A.
Straaten, H. M. Oudemans-van
Bosman, R. J.
van der Spoel, J. I.
Haak, E. A. F.
Porcelijn, L.
Zandstra, D. F.
NETHERLANDS JOURNAL OF MEDICINE, 2007, 65 (03) : 101 - 108

← 1 2 3 4 5 →